The targeting of human and mouse B lymphocytes by dasatinib.

Saved in:
Bibliographic Details
Title: The targeting of human and mouse B lymphocytes by dasatinib.
Authors: Oksvold MP; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. Electronic address: moroks@rr-research.no., Duyvestyn JM; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Dagger SA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Taylor SJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Forfang L; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Myklebust JH; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Smeland EB; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Langdon WY; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia.
Source: Experimental hematology [Exp Hematol] 2015 May; Vol. 43 (5), pp. 352-363.e4. Date of Electronic Publication: 2015 Jan 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2399
DOI:10.1016/j.exphem.2015.01.008